Ivonne Lorena Diaz Ariza

Dr. Ivonne Lorena Diaz Ariza

Química, Universidad Distrital Francisco Jose de Caldas, Bogotá, Colombia
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2015 in AAPS PharmSciTech
Verified
Journal Article
Open access
PDF file
IAIvonne Lorena Diaz Ariza
Ivonne Lorena Diaz Ariza
Claudia Marcela Marcela Parra-GiraldoClaudia Marcela Marcela Parra-Giraldo
Claudia Marcela Marcela Parra-Giraldo
MLMelva Linarez
Melva Linarez
LPLEON PEREZ
LEON PEREZ
The clinical application of amphotericin B (AmB), a broad spectrum antifungal agent, is limited by its poor solubility in aqueous medium and also by its proven renal toxicity. In this work, AmB was encapsulated in micelles obtained from the self-assembly of PDMAEMA-b-PCL-b-PDMAEMA triblock copolymers. The amount of encapsulated AmB depended on the copolymer composition, and short blocks of polycaprolactone (PCL) and poly(2-dimethylaminoethyl methacrylate) (PDMAEMA) showed better performance. All the studied formulations exhibited a controlled release of AmB along 150 h. The formulations presented reduced hemotoxicity while maintaining antifungal activities against Candida albicans, Candida krusei, and Candida glabrata comparable with free AmB. A reduction on the hemotoxicity was found to be due to the slow release and subsequent low aggregation achieved with the use of polymer micelle nanocontainers.


13 July 2020 in Journal of Polymer Science
Verified
Journal Article
Closed access
PDF file
IAIvonne Lorena Diaz Ariza
Ivonne Lorena Diaz Ariza
CSCesar A. Sierra
Cesar A. Sierra
VJValérie Jérôme
Valérie Jérôme
Ruth FreitagRuth Freitag
Ruth Freitag
LPLEON PEREZ
LEON PEREZ

12 January 2021 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
IAIvonne Lorena Diaz Ariza
Ivonne Lorena Diaz Ariza
VJValérie Jérôme
Valérie Jérôme
LPLeón D. Pérez Pérez
León D. Pérez Pérez
Ruth FreitagRuth Freitag
Ruth Freitag

28 October 2021 in Journal of Bioactive and Compatible Polymers
Verified
Journal Article
Closed access
PDF file
IAIvonne Lorena Diaz Ariza
Ivonne Lorena Diaz Ariza
VJValérie Jérôme
Valérie Jérôme
RFRuth Freitag
Ruth Freitag
LPLEON PEREZ
LEON PEREZ
Poly(ethyleneimine) (PEI) is one of the most widely used cationic polymers for gene delivery. The high molecular weight polymer, which is commercially available, is highly efficient but also very cytotoxic. The reduction in charge density by using nonlinear architectures based on low molecular weight (LMW) PEI is a promising approach to produce safer DNA-vectors. Herein, a group of cationic graft copolymers with different composition containing a hydrophobic biocompatible backbone and LMW linear PEI (lPEI) grafts obtained by ring opening polymerization and click chemistry was studied. The self-assembly and DNA complexation behavior of these materials was analyzed by the gel retardation assay, zeta potential measurements, and dynamic light scattering. The copolymers formed positively charged particles in water with average sizes between 270 and 377 nm. After they were added to DNA in serum-free medium, these particles acquired negative/near-neutral charges and increased in size depending on the N/P ratio. All copolymers showed reduced cytotoxicity compared to the 25 kDa lPEI used as reference, but the transfection efficiency was reduced. This result suggested that the cationic segments were too small to fully condense the DNA and promote cellular uptake, even with the use of several grafts and the introduction of hydrophobic domains. The trends found in this research showed that a higher degree of hydrophobicity and a higher grafting density can enhance the interaction between the copolymers and DNA. These trends could direct further structural modifications in the search for effective and safe vectors based on this polycation.

9 May 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JGJacky Michelle Guerrero
Jacky Michelle Guerrero
DSDiego Suarez
Diego Suarez
Andrés F LealAndrés F Leal
Andrés F Leal
IAIvonne Lorena Diaz Ariza
Ivonne Lorena Diaz Ariza
LPLEON PEREZ
LEON PEREZ
Carlos Javier Alméciga-DíazCarlos Javier Alméciga-Díaz
Carlos Javier Alméciga-Díaz
Background/Objectives: Tay–Sachs disease (TSD) is a neurodegenerative disorder caused by a deficiency in β-hexosaminidase A (HexA), which accumulates GM2 gangliosides, primarily in neurons. Currently, therapeutic options are limited, highlighting the need for new strategies such as gene therapy. Despite their effectiveness, viral vectors can elicit adverse immune responses; consequently, non-viral vectors are being explored as an alternative. We have previously investigated the use of CRISPR/Cas9 nickase (nCas9) as a potential tool for treating TSD. Here, we expanded our study by evaluating the PP6D5 polymer as a novel non-viral vector for delivering the CRISPR/nCas9 system to restore HexA activity. Methods: First, we evaluated the PP6D5-mediated CRISPR/nCas9 system’s transfection efficiency in NIH-3T3 fibroblasts, U87MG astrocytoma, SHSY5Y neuroblastoma, and TSD fibroblasts. We then evaluated the potential of PP6D5 to correct the gene defect in TSD fibroblasts. Results: The results showed that PP6D5 exhibited significantly higher transfection efficiency compared to lipofectamine 3000 in all tested cell models. In TSD fibroblasts, transfection with both HEXA and HEXB cDNAs increased the HexA activity levels by up to 7.4-fold, compared to a 3.2-fold increase in cells transfected only with HEXA cDNA after 15 days post-transfection. These levels were up to 4.5-fold higher than those observed in lipofectamine-mediated transfection. Additionally, PP6D5-mediated CRISPR/nCas9-based genome editing led to a significant reduction in the lysosomal mass of TSD fibroblasts. Conclusions: This study provides promising evidence for the use of the PP6D5 polymer as a non-viral vector for delivering CRISPR/nCas9-based gene therapy in TSD. The use of the PP6D5 polymer may offer some advantages that viral vectors cannot, such as a reduction in cytotoxicity and higher TE in difficult-to-transfect cell lines. Furthermore, this type of polymeric vector has not been extensively explored for gene therapy, making this study an important contribution to the development of non-viral delivery systems for the treatment of neurodegenerative diseases.